Antisense Therapeutics Limited

Antisense Therapeutics Limitedverified

ATHJF

Price:

$0.05662

Market Cap:

$141.18M

Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase II clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Th...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2009-09-08

Stock Exchange

PNK

Ticker

ATHJF

The Current Ratio as of October 2024 (TTM) for Antisense Therapeutics Limited (ATHJF) is 2.81

According to Antisense Therapeutics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 2.81. This represents a change of -20.45% compared to the average of 3.53 of the last 4 quarters.

Antisense Therapeutics Limited (ATHJF) Historical Current Ratio (quarterly & annually)

How has ATHJF Current Ratio performed in the past?

The mean historical Current Ratio of Antisense Therapeutics Limited over the last ten years is 7.58. The current 2.81 Current Ratio has changed 3.61% with respect to the historical average. Over the past ten years (40 quarters), ATHJF's Current Ratio was at its highest in in the September 2021 quarter at 25.91. The Current Ratio was at its lowest in in the March 2024 quarter at 0.

Quarterly (TTM)
Annual

Average

7.58

Median

6.47

Minimum

2.81

Maximum

19.14

Antisense Therapeutics Limited (ATHJF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Antisense Therapeutics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 198.78%

Maximum Annual Current Ratio = 19.14

Minimum Annual Increase = -76.42%

Minimum Annual Current Ratio = 2.81

Quarterly (TTM)
Annual
YearCurrent RatioChange
20242.81-37.75%
20234.51-76.42%
202219.14198.78%
20216.41-1.88%
20206.5355.41%
20194.20-49.10%
20188.25124.14%
20173.68-48.11%
20167.10-46.19%
201513.19184.03%

Antisense Therapeutics Limited (ATHJF) Average Current Ratio

How has ATHJF Current Ratio performed in the past?

The current Current Ratio of Antisense Therapeutics Limited (ATHJF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.82

5-year avg

7.88

10-year avg

7.58

Antisense Therapeutics Limited (ATHJF) Current Ratio vs. Peers

How is ATHJF’s Current Ratio compared to its peers?

Antisense Therapeutics Limited’s Current Ratio is less than Amexdrug Corporation (11.78), greater than Aion Therapeutic Inc. (0.18), greater than Aspen Pharmacare Holdings Limited (1.81), greater than Alterola Biotech, Inc. (0.08), greater than The BC Bud Corporation (2.47), less than Crescita Therapeutics Inc. (3.37), less than AusCann Group Holdings Ltd (33.22), greater than Avicanna Inc. (0.69), greater than Bionoid Pharma Inc. (0.34),

Build a custom stock screener for Antisense Therapeutics Limited (ATHJF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Antisense Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Antisense Therapeutics Limited (ATHJF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Antisense Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Antisense Therapeutics Limited's Current Ratio?

How is the Current Ratio calculated for Antisense Therapeutics Limited (ATHJF)?

What is the highest Current Ratio for Antisense Therapeutics Limited (ATHJF)?

What is the 3-year average Current Ratio for Antisense Therapeutics Limited (ATHJF)?

What is the 5-year average Current Ratio for Antisense Therapeutics Limited (ATHJF)?

How does the current Current Ratio for Antisense Therapeutics Limited (ATHJF) compare to its historical average?